Search

everythinglearnresearchcommunity

for

Search:↓

Atrazine and finasteride disrupt hormone signaling and affect frog development.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

5α-reductases increase epitestosterone's effect on androgen receptors.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

The research helps understand how finasteride works and aids drug development.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

No link found between specific genes and female pattern hair loss.